Taurocholic Acid Is Associated With Disturbed Functional Connectivity in the Hippocampus of Patients With Depression
Open Access
- 23 December 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (13) , e08693
Abstract
Major Depressive Disorder (MDD) is characterized by abnormal metabolic profiles along the microbiome‐gut‐brain axis. Bile acids (BAs), a class of steroid compounds regulated by the host and microbes, are increasingly shown to become dysregulated in models of depression. However, the identity of key regulatory BA metabolite in patients with MDD and associated mechanism remain to be clarified. Here, a prospective observational study in patients with depression ( n = 235) and control subjects ( n = 232) for identifying functional BA metabolites regulating depressive behavior and brain functional connectivity is performed. Using comparative metabolomics assay, an increased level of taurocholic acid (TCA) in the serum of patients with MDD is observed, which is reversed by anti‐depressant treatments. Transferring fecal microbiome from patients with MDD induced TCA accumulation to the hippocampus of recipient mice exhibiting depression‐like behavior. TCA supplementation suppressed hippocampal neurogenesis, triggered microglial activation, and elicited depression‐like behavior in mice, which are alleviated by a sphingosine‐1‐phosphate receptor 2 (S1PR2) antagonist. In patients with MDD, functional neuroimaging and spearman correlation analysis revealed that circulating TCA is strongly correlated with functional connectivity in the subregions of hippocampus. The results highlight the potential of harnessing TCA as a prognostic marker and therapeutic target for depression.Keywords
Funding Information
- National Key Research and Development Program of China (2024YFA1308200)
- National Natural Science Foundation of China (82571747)
- National Natural Science Foundation of China (82271570)
This publication has 42 references indexed in Scilit:
- A Gpr35-tuned gut microbe-brain metabolic axis regulates depressive-like behaviorCell Host & Microbe, 2024
- Abnormal changes of dynamic topological characteristics in patients with major depressive disorderJournal of Affective Disorders, 2023
- TGR5 deficiency-induced anxiety and depression-like behaviors: The role of gut microbiota dysbiosisJournal of Affective Disorders, 2023
- Global sphingosine-1-phosphate receptor 2 deficiency attenuates neuroinflammation and ischemic-reperfusion injury after neonatal strokeiScience, 2023
- The FXR mediated anti-depression effect of CDCA underpinned its therapeutic potentiation for MDDInternational Immunopharmacology, 2022
- Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signalingBrain, Behavior, and Immunity, 2022
- Emerging targetome and signalome landscape of gut microbial metabolitesCell Metabolism, 2022
- Intestinal hypoxia-inducible factor 2α regulates lactate levels to shape the gut microbiome and alter thermogenesisCell Metabolism, 2021
- Takeda G Protein–Coupled Receptor 5 Modulates Depression-like Behaviors via Hippocampal CA3 Pyramidal Neurons Afferent to Dorsolateral SeptumBiological Psychiatry, 2021
- Conjugated Bile Acids Activate the Sphingosine–1–Phosphate Receptor 2 in Primary Rodent HepatocytesHepatology, 2011